Literature DB >> 7519343

Energy expenditure and genotype of children with cystic fibrosis.

J L Tomezsko1, V A Stallings, D A Kawchak, J E Goin, G Diamond, T F Scanlin.   

Abstract

Increased energy expenditure, poor dietary intake, and fat malabsorption in patients with cystic fibrosis (CF) frequently lead to growth failure and malnutrition, which are associated with pulmonary failure and decreased survival. The study purpose was to understand better the energy expenditure and requirements in the mild pulmonary disease state in children. Resting and total energy expenditure were measured in 6- to 9-yr-old, pancreatic-insufficient children with CF (n = 25) and control children (n = 25) of similar age, gender, and weight. The effect of the most common genotype, homozygous delta F508, on energy expenditure was also investigated. Dietary intake, degree of fat malabsorption, body composition, physical activity, and clinical status were determined. The CF group had a 9% increase in resting energy expenditure, which was not related to genotype or severity of lung disease. Both CF genotype subgroups (delta F508 homozygous and all others) had a similar, modest resting energy expenditure increase. Total energy expenditure was increased by 12% in the entire CF group and by 23% in the delta F508 homozygous CF subgroup compared with controls. The total energy expenditure increase in delta F508 homozygous children may be related to increased voluntary physical activity, reflecting no activity reduction associated with lung disease, or to an unidentified genotype-related mechanism. The clinical implication is that a detailed physical activity assessment should be evaluated along with resting energy expenditure, either measured or estimated by equations, when daily energy needs are being determined for children with CF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519343     DOI: 10.1203/00006450-199404000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Absence of leptin signaling allows fat accretion in cystic fibrosis mice.

Authors:  Ilya R Bederman; Gavriella Pora; Maureen O'Reilly; James Poleman; Kimberly Spoonhower; Michelle Puchowicz; Aura Perez; Bernadette O Erokwu; Alex Rodriguez-Palacios; Chris A Flask; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-08-17       Impact factor: 4.052

2.  Adequacy of clinical formulae for estimation of energy requirements in children with cystic fibrosis.

Authors:  J J Reilly; T J Evans; J Wilkinson; J Y Paton
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

3.  Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain.

Authors:  A E Mulberg; L P Resta; E B Wiedner; S M Altschuler; D M Jefferson; D L Broussard
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Gender differences in habitual activity in children with cystic fibrosis.

Authors:  H C Selvadurai; C J Blimkie; P J Cooper; C M Mellis; P P Van Asperen
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

5.  Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells.

Authors:  Diana R Wetmore; Elizabeth Joseloff; Joseph Pilewski; Douglas P Lee; Kay A Lawton; Matthew W Mitchell; Michael V Milburn; John A Ryals; Lining Guo
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

6.  Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor.

Authors:  Drucy Borowitz; Barry Lubarsky; Michael Wilschanski; Anne Munck; Daniel Gelfond; Frank Bodewes; Sarah Jane Schwarzenberg
Journal:  Dig Dis Sci       Date:  2015-08-07       Impact factor: 3.199

Review 7.  Growth hormone and exercise tolerance in patients with cystic fibrosis.

Authors:  Matthias Hütler; Ralph Beneke
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

8.  Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic Fibrosis.

Authors:  Monica Gelzo; Paola Iacotucci; Vincenzo Carnovale; Alice Castaldo; Marika Comegna; Gustavo Cernera; Gaetano Corso; Giuseppe Castaldo
Journal:  Diagnostics (Basel)       Date:  2020-11-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.